Cargando…
Low-intensity regimens versus standard-intensity induction strategies in acute myeloid leukemia
Treatment options for elderly patients with acute myeloid leukemia (AML) remain limited. In this age group, AML is frequently associated with poor-risk features, while patients’ present comorbidities and reduced functional reserves. As such, intensive chemotherapy (ICT) is frequently too toxic or in...
Autor principal: | Vey, Norbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081460/ https://www.ncbi.nlm.nih.gov/pubmed/32215195 http://dx.doi.org/10.1177/2040620720913010 |
Ejemplares similares
-
Advancing the standard: venetoclax combined with intensive induction and consolidation therapy for acute myeloid leukemia
por: Lachowiez, Curtis A., et al.
Publicado: (2022) -
Dose intensity for induction in acute myeloid leukemia: what, when, and for whom?
por: McCurdy, Shannon R., et al.
Publicado: (2021) -
Low-intensity induction in acute myeloid leukemia. Always in the patients' best interest?
por: Atallah, Ehab
Publicado: (2022) -
The outcome and prognostic factors of 248 elderly patients with acute myeloid leukemia treated with standard-dose or low-intensity induction therapy
por: Chen, Yi, et al.
Publicado: (2016) -
Update on current treatments for adult acute myeloid leukemia: to treat acute myeloid leukemia intensively or non-intensively? That is the question
por: Jaramillo, Sonia, et al.
Publicado: (2023)